NCT02806193

Brief Summary

The Global CMR Registry aims to promote collaboration of CMR sites worldwide in setting imaging and reporting standards, assessing its diagnostic impact on patient care, and determining the cost-effectiveness of CMR imaging. It will be the largest collective body of evidence reflecting the current clinical applications in patient care, which healthcare payers and governing bodies alike can depend on when metrics such as testing appropriateness, common indications, and diagnostic effectiveness are called for. It will also be able to reflect any changes in patient impact from CMR over time as technical development evolves. Furthermore, it will allow an assessment of improvements in diagnostic and therapeutic thinking, risk stratification, and cost-effectiveness relevant to current patient management.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80,000

participants targeted

Target at P75+ for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

June 13, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 20, 2016

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Last Updated

June 20, 2016

Status Verified

June 1, 2016

Enrollment Period

6.9 years

First QC Date

June 13, 2016

Last Update Submit

June 17, 2016

Conditions

Keywords

cardiovascularcardiacMRICMRCTECGmagnetic resonanceimaging

Outcome Measures

Primary Outcomes (3)

  • Mortality

    death from various causes including cardiovascular death

    Mortality will be tracked through study completion, for each year

  • Heart Failure

    heart failure development or worsening of heart failure

    Through study completion, for each year

  • Acute myocardial infarction

    Through study completion, for each year

Secondary Outcomes (4)

  • Cardiac Intervention (Implantable cardioverter-defibrillator or ICD)

    Through study completion, for each year

  • Cardiac Intervention (pacemakers)

    Through study completion, for each year

  • Cardiac Intervention (cardiac surgery)

    Through study completion, for each year

  • Cardiac Intervention (coronary revascularization)

    Through study completion, for each year

Study Arms (1)

Cardiovascular Magnetic Resonance Imaging

Cardiovascular imaging techniques (other subsidiary techniques such as CT and ECG will also be followed)

Procedure: Cardiovascular Magnetic Resonance Imaging

Interventions

Cardiac magnetic resonance imaging (CMR) has emerged as both a remarkably powerful diagnostic and prognostic tool for the assessment of cardiovascular disease. The high spatial resolution of CMR and the ability to characterize soft tissue provides the opportunity for unique diagnostic assessment of a myriad of cardiac pathology, including ischemic heart disease (IHD), preoperative assessment, intra- cardiac mass and thrombus, pericardial disease, valvular heart disease, and cardiomyopathy evaluation. Between individual CMR programs, GCMR will offer information useful in assessing the differences in protocol, performance, and clinical adaptation by varying geographic regions, institutional environments, and expertise. Such an assessment is critical for uncovering possible reasons for disparities in performance and obtaining opportunities for advancement.

Cardiovascular Magnetic Resonance Imaging

Eligibility Criteria

AgeUp to 89 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The registry data will be collected from patients of various clinical CMR sites that have agreed to contribute their data to the registry.

You may qualify if:

  • Cardiovascular disease, underwent CMR, CT, or ECG

You may not qualify if:

  • Patients who are 90 years and older

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Global Cardiovascular Magnetic Resonance Registry (GCMR) Investigators; Kwong RY, Petersen SE, Schulz-Menger J, Arai AE, Bingham SE, Chen Y, Choi YL, Cury RC, Ferreira VM, Flamm SD, Steel K, Bandettini WP, Martin ET, Nallamshetty L, Neubauer S, Raman SV, Schelbert EB, Valeti US, Cao JJ, Reichek N, Young AA, Fexon L, Pivovarov M, Ferrari VA, Simonetti OP. The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developments. J Cardiovasc Magn Reson. 2017 Jan 20;19(1):23. doi: 10.1186/s12968-016-0321-7.

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Raymond Y. Kwong, MD, MPH

    Brigham and Women's Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2016

First Posted

June 20, 2016

Study Start

January 1, 2014

Primary Completion

December 1, 2020

Last Updated

June 20, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will share

Participating sites will send relevant de-identified to the data management team for harmonization. The aggregate data will be used for retrospective analyses and research. Researchers requesting data access for either grant proposals or sub-studies will be required to submit a proposal to the GCMR steering committee (composed of various experts in the CMR community) for approval. If approved, data access will be given to the researchers for a specific time period determined by the magnitude of the work involved, and only for the purposes of the grant proposal or sub-study.